US FDA’s Anti-Misinformation Campaigns Look Safer After Supreme Court Oral Arguments

 
• By Sarah Karlin-Smith
outside of the US Supreme Court building
The Supreme Court heard oral arguments on 18 March in a case stemming from government actions on COVID-19 misinformation. • Source: Shutterstock (Erik Cox Photography)

More from Legal & IP

More from Pink Sheet